DOCSLIB.ORG

Thomaskileylegal00generich.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Thomaskileylegal00generich.Pdf of University California Berkeley Regional Oral History Office University of California The Bancroft Library Berkeley, California Program in the History of the Biological Sciences and Biotechnology Thomas D. Kiley GENENTECH LEGAL COUNSEL AND VICE PRESIDENT, 1976-1988, AND ENTREPRENEUR With Introductions by Rebecca S. Eisenberg James W. Geriak Interviews Conducted by Sally Smith Hughes, Ph.D. in 2000 and 2001 Copyright 2002 by The Regents of the University of California Since 1 954 the Regional Oral History Office has been interviewing leading participants in or well-placed witnesses to major events in the development of northern California, the West, and the nation. Oral history is a method of collecting historical information through tape-recorded interviews between a narrator with firsthand knowledge ofhistorically significant events and a well-informed interviewer, with the goal of preserving substantive additions to the historical record. The tape recording is transcribed, lightly edited for continuity and clarity, and reviewed by the interviewee. The corrected manuscript is indexed, bound with photographs and illustrative materials, and placed in The Bancroft Library at the University of California, Berkeley, and in other research collections for scholarly use. Because it is primary material, oral history is not intended to present the final, verified, or complete narrative of events. It is a spoken account, offered by the interviewee in response to questioning, and as such it is reflective, partisan, deeply involved, and irreplaceable. ************************************ All uses of this manuscript are covered by a legal agreement between The Regents of the University of California and Thomas D. Kiley dated March 12, 2001. The manuscript is thereby made available for research purposes. All literary rights in the manuscript, including the right to publish, are reserved to The Bancroft Library of the University of California, Berkeley. No part of the manuscript may be quoted for publication without the written permission of the Director of The Bancroft Library of the University of California, Berkeley. Requests for permission to quote for publication should be addressed to the Regional Oral History Office, 486 Bancroft Library, Mail Code 6000, University of California, Berkeley 94720-6000, and should include identification of the specific passages to be quoted, anticipated use of the passages, and identification of the user. It is recommended that this oral history be cited as follows: Thomas D. Kiley, "Genentech Legal Counsel and Vice President, 1976-1988, and Entrepreneur," an oral history conducted in 2000 and 2001 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California, Berkeley, 2002. Copy no. Thomas D. Kiley, 2002 photo credit: Doerr Studios Cataloguing information Thomas D . Kiley (b . 1 943 ) Patent Attorney/Entrepreneur Genentech Legal Counsel and Vice President, 1976-1988, and Entrepreneur, 2002, xi, 217 pp. Education in chemical engineering, law; early experiences as patent examiner and patent solicitor; intellectual property trial lawyer, Lyon & Lyon; outside legal counsel to Genentech, 1976-1980; vice president and general counsel, Genentech, 1980-1988: Genentech s IPO, 1980; Diamond v. Chakrabarty Supreme Court case; recombinant DNA; commercialization of biotechnology; intellectual property; R&D clinical partnerships, patenting and licensing; Genentech-University of California legal relationships; Bayh-Dole Act, 1980; Genencor; Geron; Intermune Pharmaceuticals; NIH-DOE Joint Committee on the Human Genome, 1992; comments on Herb Boyer, Dave Goeddel, Robert Swanson and others. Introductions by Rebecca S. Eisenberg, Professor, University of Michigan Law School; and James W. Geriak, Partner, Orrick, Herrington & Sutcliffe, Irvine, CA. Interviewed in 2000 and 200 1 by Sally Smith Hughes for the Program in the History of Biosciences and Biotechnology, Regional Oral History Office, The Bancroft Library, University of California, Berkeley. TABLE OF CONTENTS-Thomas D. Kiley BIOTECHNOLOGY SERIES HISTORY by Sally Smith Hughes i BIOTECHNOLOGY SERIES LIST iii iv INTRODUCTION by Rebecca S . Eisenberg INTRODUCTION by James W. Geriak vi INTERVIEW HISTORY by Sally Smith Hughes viii BIOGRAPHICAL INFORMATION ix I FAMILY BACKGROUND AND EDUCATION Grandparents Higher Education and Early Experience in Patent Law Undergraduate, Pennsylvania State University, 1961-1965 George Washington University Law School, 1966-1969 Choosing the Law over Chemical Engineering as a Career Attraction to Patent Law 4 Examiner, United States Patent and Trademark Office, 1965-1 967 4 4 Patent Solicitor, E. I. du Pont de Nemours and Company, 1967-1969 H INTELLECTUAL PROPERTY TRIAL LAW, LYON AND LYON, 1969-1980 5 The Firm Dealing with Scientists First Court Appearance 6 Impact of Biotechnology on Intellectual Property Law Patent Litigation Cases m GENENTECH, INC.: OUTSIDE PATENT COUNSEL, 1976-1980 9 First Encounter with Robert Swanson, June 1976 Previous Experience with Intellectual Property in Biology 10 10 DNA Synthesis of Somatostatin Commercial Application of Recombinant DNA 10 Somatostatin to Demonstrate Proof of Principle The Research Team and Its Approach Failure and Then Success Resistance to the Commercialization of Academic Biology 14 Fear of Biohazard and the NTH Guidelines for Recombinant DNA Research 1 6 Threat of Federal Regulatory Legislation, 1977-1979 Drawn to Swanson and His Corporate Mission 1 8 Company Policy on Patenting and Publication Strategies to Achieve Profitability 19 Initial Public Offering, October 1980 20 The Diamond v. Chakrabarty Supreme Court Case 20 Regents ofthe University of California v. Hoffmann-La Roche, Inc. 22 and Genentech, Inc. Peter Seeburg, Axel Ullrich, and Allegations of Stolen Cell Lines 23 Legal Counsel for the University 24 Genentech Settles with the University of California 25 International Nickel 26 IV GENENTECH 27 Swanson s Initial Vision of Genentech 27 Early Applications of Recombinant DNA Technology 28 Focus on Pharmaceuticals 28 Technological Risk-Benefit Ratio 29 Congressional Testimony 30 Locating Genentech in South San Francisco 30 Early Business Plans 3 1 Early Diffuse Corporate Focus 32 Negotiating Research Agreements 33 Recombinant Human Insulin 34 The Contract with Eli Lilly 34 The Gilbert and UCSF Insulin Projects 35 More on the Somatostatin Project 36 Contract with the University of California 36 Disagreement over Inventorship 37 Early Patents 38 Patents in Early Biotechnology 39 Role in Corporate Financing 39 More on the Chakrabarty Decision 39 More on Genentech s Initial Public Offering 40 The Interferons 41 Recombinant Human Growth Hormone 42 The Cloning Race 42 Patent Rights 43 University of California v. Genentech, 1999 43 A Settlement with UC, 1980 45 Genentech s Corporate Evolution 46 More on Swanson s Initial Vision 46 Hoffmann-La Roche Gains Controlling Interest 47 Ho-hos 48 Genentech Work Ethic 50 More on Kiley s Decision to Join Genentech 50 Kiley s Association with Hybritech 5 1 Kiley s Early Concerns at Genentech 52 Genentech and the Cohen-Boyer Patent 52 The Status of Patents in Biotechnology 53 More on Diamond v. Chakrabarty 54 U. S. Patent Office Handling of Biotechnology Patents Genentech: Growing the Business 56 Intellectual Property and Contract Partnering Models Syntex and Alza: Positive and Negative Business 58 Swanson: Organizational Development and Contract Negotiation Genentech: Patent Prosecution and Litigation Gamma Interferon 60 Tissue Plasminogen Activator Human Growth Hormone: The Hoffmann-La Roche Suit 62 Urokinase: The Abbott Laboratories Suit 63 63 Factor VET: Scripps Research Institute Human Growth Hormone: The Eli Lilly Suit 63 65 tPA: The Wellcome Trust Litigations tPA as a Possible Product 65 The Wellcome Suit in the United Kingdom 66 70 Failing to Patent Monoclonal Antibody Technology A Surfeit of Patents in Biotechnology Patents in Biotechnology: Issues Raised Patenting Nature 74 Utility Deleterious Effects of Patent Barriers 74 The Patent Prosecution Process 76 Working with Scientists 76 Scientific Publication Enablement Changes in the Patenting Landscape in Biotechnology 79 Looking Back at Early Patent Prosecution at Genentech More on Genentech in the Early Days Assessing the Company for Investment Road Shows Process Patents and Foreign Infringement The Changing Value of Patents 84 V GENENTECH LEGAL COUNSEL, 1980-1988 Intellectual Property Issues at Genentech The Interferons The Riggs-Itakura Patent Patenting and Licensing Strategies Fending Off Litigation from Licensees Academic Freedoms at Genentech 94 Concern about the Commercialization of Biology 96 The American Type Culture Collection of Microorganisms 97 Genentech Culture and Financing 100 R&D Clinical Partnerships The Agreement with Kabi Vitrum on Human Growth Hormone 100 Extraterritorial Licensing Rights Genentech-UC Legal Relationships 102 Observations on the Biotechnology Industry and Factors Affecting It 103 Biotechnology Clusters in the U. S. 103 The Bayh-Dole Act, 1980 104 Testifying at a Congressional Subcommittee, 1983 105 Court of Appeals for the Federal Circuit 105 More on the Commercialization of Biology 106 Comments on the U. S. Patent System 107 VI CORPORATE VENTURES BEYOND GENENTECH 109 Genencor 109 Leaving Genentech, 1988 110 Evolving Corporate Culture in Biotechnology 111 Athena Neurosciences 112 CellPro 113 Technology Platform 113 CellPro-Baxter Litigation 1 1 3 Two Catastrophes 114 The Bayh-Dole Act and an Aborted
Load more

Recommended publications
  • Race and Membership in American History: the Eugenics Movement
    Race and Membership in American History: The Eugenics Movement Facing History and Ourselves National Foundation, Inc. Brookline, Massachusetts Eugenicstextfinal.qxp 11/6/2006 10:05 AM Page 2 For permission to reproduce the following photographs, posters, and charts in this book, grateful acknowledgement is made to the following: Cover: “Mixed Types of Uncivilized Peoples” from Truman State University. (Image #1028 from Cold Spring Harbor Eugenics Archive, http://www.eugenics archive.org/eugenics/). Fitter Family Contest winners, Kansas State Fair, from American Philosophical Society (image #94 at http://www.amphilsoc.org/ library/guides/eugenics.htm). Ellis Island image from the Library of Congress. Petrus Camper’s illustration of “facial angles” from The Works of the Late Professor Camper by Thomas Cogan, M.D., London: Dilly, 1794. Inside: p. 45: The Works of the Late Professor Camper by Thomas Cogan, M.D., London: Dilly, 1794. 51: “Observations on the Size of the Brain in Various Races and Families of Man” by Samuel Morton. Proceedings of the Academy of Natural Sciences, vol. 4, 1849. 74: The American Philosophical Society. 77: Heredity in Relation to Eugenics, Charles Davenport. New York: Henry Holt &Co., 1911. 99: Special Collections and Preservation Division, Chicago Public Library. 116: The Missouri Historical Society. 119: The Daughters of Edward Darley Boit, 1882; John Singer Sargent, American (1856-1925). Oil on canvas; 87 3/8 x 87 5/8 in. (221.9 x 222.6 cm.). Gift of Mary Louisa Boit, Julia Overing Boit, Jane Hubbard Boit, and Florence D. Boit in memory of their father, Edward Darley Boit, 19.124.
    [Show full text]
  • Boundary Issues
    documents that are not necessarily merger specific are The US example highlights the collaboration between the often the subject of these requests. There have been cases DOJ's civil and criminal sections. The fines in the European in which documents submitted pursuant to a request issued cases serve to remind companies that the exchange of in the context of a merger investigation have triggered commercially sensitive information may be forbidden by competition law concerns unrelated to the merger. competition rules. Similarly, the examples from the rest of the For example, when various franchise agreements were world emphasise the growing risks and implications following requested as part of a merger investigation,the Competition the submission of documents to antitrust authorities. Commission expressed concerns with exclusivity provisions Companies need to be increasingly aware of the risks contained in the agreements, claiming that they would ordinary course documents present, and implement proper have a restrictive effect on competition. The Competition document management procedures, as well as compliance Tribunal, the adjudicative body deliberating upon the programmes to ensure compliance with the relevant merger, noted that non-merger specific antitrust issues competition laws. Whilst easy to state, ongoing compliance cannot be investigated through the "back door of merger with competition law is the most straightforward way to control" but invited the Competition Commission to ensure that documents submitted for a merger review tell investigate its concerns separately. the story the merging parties want to be told. In a case involving a merger investigation of property funds, lease exclusivity provisions were raised by the Pou! Johnson is of counsel, Craig Lee is a partner, and Creighton Competition Commission as a concerning feature ofthe way Macy is a partner at Baker McKenzie in Brussels and Washington DC.
    [Show full text]
  • Eugenomics: Eugenics and Ethics in the 21 Century
    Genomics, Society and Policy 2006, Vol.2, No.2, pp.28-49 Eugenomics: Eugenics and Ethics in the 21st Century JULIE M. AULTMAN Abstract With a shift from genetics to genomics, the study of organisms in terms of their full DNA sequences, the resurgence of eugenics has taken on a new form. Following from this new form of eugenics, which I have termed “eugenomics”, is a host of ethical and social dilemmas containing elements patterned from controversies over the eugenics movement throughout the 20th century. This paper identifies these ethical and social dilemmas, drawing upon an examination of why eugenics of the 20th century was morally wrong. Though many eugenic programs of the early 20th century remain in the dark corners of our history and law books and scientific journals, not all of these programs have been, nor should be, forgotten. My aim is not to remind us of the social and ethical abuses from past eugenics programs, but to draw similarities and dissimilarities from what we commonly know of the past and identify areas where genomics may be eugenically beneficial and harmful to our global community. I show that our ethical and social concerns are not taken as seriously as they should be by the scientific community, political and legal communities, and by the international public; as eugenomics is quickly gaining control over our genetic futures, ethics, I argue, is lagging behind and going considerably unnoticed. In showing why ethics is lagging behind I propose a framework that can provide us with a better understanding of genomics with respect to our pluralistic, global values.
    [Show full text]
  • Honors Fellows - Spring 2019
    Honors Fellows - Spring 2019 Maya Aboutanos (Dr. Katherine Johnson) Public Health Investigating the Relationship between Spirituality and Health: A Case Study on a Holistic Health Care Facility in North Carolina’s Piedmont Region Betsy Albritton (Dr. Christopher Leupold) Psychology Construction of an Assessment Center for Entry-Level Professionals Serena Archer (Dr. Tony Weaver) Sport Management A Qualitative Analysis of the Intersectional Socialization of NCCAA Division I Student-Athletes Across Diverse Identities Jenna Bayer (Dr. Brian Lyons) Human Resource Reexamining the Demand for Human Resource Certification in Management/Marketing the United States Judah Brown (Dr. Brandon Sheridan) Economics The Impact of National Anthem Protests on National Football League Television Ratings Anna Cosentino (Dr. Derek Lackaff) Media Analytics Using Geolocated Twitter Sentiment to Advise Municipal Decision Making Michael Dryzer (Dr. Scott Wolter) Biophysics Sustainable Sanitation in the Developing World: Deactivating Parasitic Worm Eggs in Wastewater using Electroporation Natalie Falcara (Dr. Christopher Harris) Finance The Financial Valuation of Collegiate Athletics: How Does a Successful Season and Gender of the Sport Impact Financial Donations? Josh Ferno (Dr. Jason Husser) Policy Studies/Sociology What Drives Support for Self-Driving Cars? Evidence from a Survey-Based Experiment Honors Fellows - Spring 2019 Jennifer Finkelstein (Dr. Buffie Longmire-Avital) Public Health/Psychology She Does Not Want Me to Be Like Her: Eating Pathology Risk in Black Collegiate Women and the Role of Maternal Communication Becca Foley (Dr. Barbara Gaither) Strategic Communications/ Exploring Alignment between Stated Corporate Values and Spanish Corporate Advocacy on Environmental and Social Issues Joel Green (Dr. Ariela Marcus-Sells) Religious Studies From American Apocalypse to American Medina: Black Muslim Theological Responses to Racial Injustice in the United States Selina Guevara (Dr.
    [Show full text]
  • Eugenics, Biopolitics, and the Challenge of the Techno-Human Condition
    Nathan VAN CAMP Redesigning Life The emerging development of genetic enhancement technologies has recently become the focus of a public and philosophical debate between proponents and opponents of a liberal eugenics – that is, the use of Eugenics, Biopolitics, and the Challenge these technologies without any overall direction or governmental control. Inspired by Foucault’s, Agamben’s of the Techno-Human Condition and Esposito’s writings about biopower and biopolitics, Life Redesigning the author sees both positions as equally problematic, as both presuppose the existence of a stable, autonomous subject capable of making decisions concerning the future of human nature, while in the age of genetic technology the nature of this subjectivity shall be less an origin than an effect of such decisions. Bringing together a biopolitical critique of the way this controversial issue has been dealt with in liberal moral and political philosophy with a philosophical analysis of the nature of and the relation between life, politics, and technology, the author sets out to outline the contours of a more responsible engagement with genetic technologies based on the idea that technology is an intrinsic condition of humanity. Nathan VAN CAMP Nathan VAN Philosophy Philosophy Nathan Van Camp is postdoctoral researcher at the University of Antwerp, Belgium. He focuses on continental philosophy, political theory, biopolitics, and critical theory. & Politics ISBN 978-2-87574-281-0 Philosophie & Politique 27 www.peterlang.com P.I.E. Peter Lang Nathan VAN CAMP Redesigning Life The emerging development of genetic enhancement technologies has recently become the focus of a public and philosophical debate between proponents and opponents of a liberal eugenics – that is, the use of Eugenics, Biopolitics, and the Challenge these technologies without any overall direction or governmental control.
    [Show full text]
  • Lex 100 P014-024 Winners.Qxp 17/08/2007 15:08 Page 14
    Lex 100 p014-024 Winners.qxp 17/08/2007 15:08 Page 14 Job satisfaction How would you rate your overall job satisfaction? Lex 100 winners 1 Farrer & Co 9.10 2 Harbottle & Lewis LLP 9.00 Analysis = McDermott Will & Emery UK LLP 9.00 This important category is topped this year by Farrer & Co in what’s = Skadden, Arps, Slate, Meagher & Flom (UK) LLP 9.00 been a highly impressive overall performance – the firm appears in every single one of our Lex 100 5 Cleary Gottlieb Steen & Hamilton LLP 8.75 Winners tables, often near the top, the first firm to do so. So why is this 6 Covington & Burling LLP 8.71 mid-sized London firm so popular with trainees? It certainly sounds a fun place 7 Latham & Watkins 8.67 to work and offers six seats in a wide variety of practice areas. There’s a strong 8 Ashfords 8.63 bond between current trainees, who praise the ‘great people and great mix of work’, ‘unique atmosphere’ and ‘sheer breadth of training = Stephens & Scown 8.63 opportunities’. Media boutique Harbottle & Lewis comes next. Trainees here feel they have ‘considerably 10 Bristows 8.60 better quality work than peers, better experience and more exposure’. Then, as last year, there’s a strong showing = Shoosmiths 8.60 by five US firms: McDermott Will & Emery, Skadden, Arps, Slate, Meagher & Flom, Cleary Gottlieb, Covington & 12 Browne Jacobson LLP 8.58 Burling and Latham & Watkins. These firms have not been offering training contracts for that long in London and all have 13 Birketts 8.50 limited intakes.
    [Show full text]
  • Globalisation, Human Genomic Research and the Shaping of Health: an Australian Perspective
    Globalisation, Human Genomic Research and the Shaping of Health: An Australian Perspective Author Hallam, Adrienne Louise Published 2003 Thesis Type Thesis (PhD Doctorate) School School of Science DOI https://doi.org/10.25904/1912/1495 Copyright Statement The author owns the copyright in this thesis, unless stated otherwise. Downloaded from http://hdl.handle.net/10072/367541 Griffith Research Online https://research-repository.griffith.edu.au Globalisation, Human Genomic Research and the Shaping of Health: An Australian Perspective Adrienne Louise Hallam B.Com, BSc (Hons) School of Science, Griffith University Submitted in fulfilment of the requirements of the degree of Doctor of Philosophy September 2002 Abstract This thesis examines one of the premier “big science” projects of the contemporary era ⎯ the globalised genetic mapping and sequencing initiative known as the Human Genome Project (HGP), and how Australia has responded to it. The study focuses on the relationship between the HGP, the biomedical model of health, and globalisation. It seeks to examine the ways in which the HGP shapes ways of thinking about health; the influence globalisation has on this process; and the implications of this for smaller nations such as Australia. Adopting a critical perspective grounded in political economy, the study provides a largely structuralist analysis of the emergent health context of the HGP. This perspective, which embraces an insightful nexus drawn from the literature on biomedicine, globalisation and the HGP, offers much utility by which to explore the basis of biomedical dominance, in particular, whether it is biomedicine’s links to the capitalist infrastructure, or its inherent efficacy and efficiency, that sustains the biomedical paradigm over “other” or non-biomedical health approaches.
    [Show full text]
  • Who'swholegal
    WHO'SWHOLEGAL LDITORIA[ BOARD PRAO_ ICE AREA ANALYSES LAWYER PROF I .LS DIRECTORY LIFE SCIENCES PATENT LITIGATION PRODUCT _IABILITY DEFENCE REGU_ATORY TRANSACTIO\A ANALYSIS PROFILES DIRECTORY wwiv. whoswholegal. corn LIFE SCIENCES I PATENT LITIGATION 703 FINLAND FRANCE ELLA MIKKOLA SABINE AGE Bird & Bird Attorneys Ltd Véron & Associés Mannerheimintie 8, Helsinki, 00100 I , rue Volney Tel: +358 9 622 6670 Paris, 75002 Fax: +358 9 622 6677 Tel: +33 I 47 03 62 62 el [email protected] Fax: +33 I 47 03 62 69 www.twobirds.com [email protected] www.veron.com Ella is highly acclaimed by rivals and clients She is head of the intellectual property Admitted to the Paris Bar in 1994, Sabine Véron & Associés maintains close group and life sciences group in Finland. Agé has been dedicating herself exclusively relationship with top -tier independent She has gained extensive experience in to patent litigation since she became a law firms in other jurisdictions, which intellectual property (IP) and life sciences law, partner of Véron & Associés at the creation can handle parallel proceedings in multi- including various contractual and litigation of the firm in 2001. jurisdictional cases. matters as well as regulatory proceedings concerning pricing and reimbursement of Véron & Associés is a law firm of 14 lawyers, She is co- author of Saisie -contrefaçon, pharmaceuticals. assisted by two scientific consultants, an published by the leading French publisher economic litigation consultant, a graphic Dalloz and edited by Pierre Véron (third In addition to her Finnish law degree from designer and translators, dealing exclusively edition, 2012). the University of Turku in 1995, Ella has a with patent litigation for French and US master's degree (LLM) in intellectual international clients.
    [Show full text]
  • Addleshaw Goddard Hong Kong Training Contract
    Addleshaw Goddard Hong Kong Training Contract politicizesJotham volatilize very allopathically. irrelevantly ifFowler equipotent barricadoes Stacy pup off-the-record. or overtook. Lozenged Humphrey queers her knurs so extrinsically that Lincoln Y Law enforcement training facility successfully protests U Constitution the law field said. Addleshaw Goddard has appointed David Kirchin as worth of Scotland for software firm. Burges Salmon Osborne Clarke and Addleshaw Goddard have advised. Lawyer salary Which training contracts pay the benefit The Tab. Csr events for hong kong high in addleshaw goddard hong kong training contract for hong kong the addleshaw goddard, employment are an indonesian local and try again or go through an application stands out and! Department who State's vegetable of marital contract for training and exportation of. Can be in hong kong and train in the contracts and communications; it is always adequately equipped, enabling push them. Tokyo hong kong beijing melbourne sydney Sullivan Cromwell. Each year research firm receives around 2000 vacation advice and direct training contract applications combined At said initial application stage an HR source tells us. Ashurst News Analysis and Updates Page 1 of 25 Legal. CMS Cameron McKenna Nabarro Olswang and Addleshaw Goddard are among. Ropes Gray has launched its debut Tokyo training contract program in. Salary London 400 pw Salary Hong Kong 2500 HKD pw Location London. 23 Norton Rose Fulbright Addleshaw Goddard Mishcon de Reya and HFW. Giles qualified as a solicitor with Addleshaw Goddard in Manchester and. Lawyers from the Hong Kong offices of Clifford Chance Herbert Smith. Dec 03 2020 Applying for a training contract at Gowling WLG.
    [Show full text]
  • 19 December 2018 Dear Member Evening Meeting at Bristows LLP
    www.competitionlawassociation.org.uk www.ligue.org 19 December 2018 Dear Member Evening Meeting at Bristows LLP: Tuesday 15 January, 2019 at 6.00 pm The CLA will be holding an evening meeting on Tuesday 15 January at Bristows LLP, 100 Victoria Embankment, London EC4Y 0DH. Registration for the event will start at 6pm followed by the talk and opportunity for discussion at 6:15pm. David Rosenberg and Darren Smyth have kindly agreed to speak on the following subject: “Lyrica in the Supreme Court: broader lessons for pharmaceuticals” There was much excitement surrounding the Supreme Court’s judgment in November on Pfizer’s second medical use patent for Pregabalin for pain (Pfizer’s blockbuster Lyrica drug). Now that the dust has settled, we will discuss the broader implications for the pharmaceutical sector and the competitive framework for drugs with both patented and unpatented uses. David Rosenberg is a solicitor and, until the end of the year, is Vice President IP Policy at GlaxoSmithKline. Before he joined GSK in 2000, he was in the IP department at a major City law firm. Since then, he has handled GSK external IP policy work and been deeply involved in such matters as work on access to medicines and the UPC. He sits on many trade associations and chairs the IP committee of EFPIA (the European innovative pharmaceutical trade association). He was deeply involved in the European Commission Sector Inquiry into the Pharmaceutical Industry. Darren Smyth is a UK and European Patent Attorney and is the head of EIP's chemistry practice group EIP Elements.
    [Show full text]
  • Understanding Genetics: DNA, Genes, and Their Real-World Applications Parts I & II Professor David Sadava
    Understanding Genetics: DNA, Genes, and Their Real-World Applications Parts I & II Professor David Sadava THE TEACHING COMPANY ® Table of Contents Understanding Genetics: DNA, Genes, and Their Real-World Applications Professor Biography..............................................................................................................................................iii Course Scope...........................................................................................................................................................1 Lecture One Our Inheritance...................................................................................................................................2 Lecture Two Mendel and Genes..............................................................................................................................4 Lecture Three Genes and Chromosomes................................................................................................................7 Lecture Four The Search for the Gene—DNA.......................................................................................................9 Lecture Five DNA Structure and Replication.......................................................................................................12 Lecture Six DNA Expression in Proteins..............................................................................................................14 Lecture Seven Genes, Enzymes, and Metabolism.................................................................................................17
    [Show full text]
  • Postgraduate Diploma in INTELLECTUAL PROPERTY LAW and PRACTICE 2020–21
    OIPRC Postgraduate Diploma in Oxford Intellectual Property Research Centre INTELLECTUAL PROPERTY LAW AND PRACTICE 2020–21 The Oxford Diploma in IP Law and Practice is a postgraduate vocational course suitable for anyone committed to a career in intellectual property. It is a one-year, part-time course taught by senior practitioners and leading academics that blends academic rigour and practical insight. The Diploma was established in 2008 as a result of a unique collaboration between the Oxford Law Faculty and the Intellectual Property Lawyers’ Association. It is now firmly established as the leading course of its kind. The path to professional practice in Intellectual Property The Diploma provides a professional development programme in an area of enormous national and international importance. It is suitable for those who are new to IP, as well as those who are looking to deepen their knowledge (the Diploma covers a wide range of issues, including the relationship between IP and competition law, IP and tax and IP and private international law that are generally neglected on other courses). The Diploma comprises a two-week residential programme held in September at Merton College, Oxford, and a series of weekend workshops held from October to June in London law firms. It is taught by a mix of practising and academic lawyers, and covers the full range of IP subjects (including Patents, Trade Marks, Unfair Competition and Passing Off, Trade Secrets, Designs, Copyright and Moral Rights) as well as key aspects of litigious and non-litigious IP practice and procedure. 2 WWW.LAW.OX.AC.UK WELCOME FROM A unique collaboration between the Professor Anne Davies Dean of the Faculty of Law Oxford Law Faculty and the Intellectual Welcome to the Oxford Property Lawyers’ Association Diploma in Intellectual Property Law and Practice.
    [Show full text]